Loading...
XASX
VFY
, Last price  
AUD
Name

Vitrafy Life Sciences Ltd

Chart & performance

D1W1MN
XASX:VFY chart
P/E
—
P/S
—
EPS
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vitrafy Life Sciences Limited has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets, cell & gene therapies, aquaculture and bovine reproduction. The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems. Vitrafy has designed and developed an innovative cryopreservation solution, which includes smart cryopreservation medical devices and packaging, and a sample quality management software platform known as LifeChain.

Key people

Leigh Farrell
Chairman of the Board · since 2025
Independent Non-Executive Chairman of the Board · since 2023
Brenton Owens
Deputy Chief Executive Officer, Co-Founder, Executive Director
Simon Martin
Chief Financial Officer · since 2024
Michael Sapountzis
Company Secretary · since 2024
Non-Executive Director · since 2025
Vaughan Webber
Non-Executive Director · since 2022
IPO date
Nov 26, 2024
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

No data to show